Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly
- PMID: 29636634
- PMCID: PMC5881283
- DOI: 10.2147/RMHP.S130405
Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly
Abstract
Pneumococcal pneumonia is a serious disease with considerable morbidity and mortality in the elderly. Despite adequate antibiotic treatment, the long-term mortality of pneumococcal pneumonia remains high. Preventive measures in the form of vaccination, therefore, are warranted. Twenty-three-valent polysaccharide vaccines have a broad coverage but limited efficacy. Pneumococcal conjugate vaccines have been shown in children to be able to prevent invasive and mucosal pneumococcal diseases. It should be realized that the serotype composition of current pneumococcal conjugate vaccines is not tailored for the elderly, and that replacement disease can occur. Yet, the current 13-valent conjugate vaccine has been shown to protect against infections with vaccine serotypes. Long-term mortality of pneumococcal pneumonia should be included in policy making about the introduction of these vaccines for the elderly.
Keywords: Streptococcus pneumoniae; conjugate vaccines; cost-effectiveness; elderly; pneumonia; vaccination.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures



Similar articles
-
Advances in pneumococcal vaccines: what are the advantages for the elderly?Drugs Aging. 2007;24(10):791-800. doi: 10.2165/00002512-200724100-00001. Drugs Aging. 2007. PMID: 17896829 Review.
-
Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.Clin Microbiol Infect. 2013 Oct;19 Suppl 1:1-9. doi: 10.1111/1469-0691.12320. Clin Microbiol Infect. 2013. PMID: 24083785 Review.
-
Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study.Vaccine. 2019 May 9;37(21):2797-2804. doi: 10.1016/j.vaccine.2019.04.017. Epub 2019 Apr 17. Vaccine. 2019. PMID: 31005428
-
[Invasive pneumococcal disease in two non-vaccinated pediatric cases: pleural empyema and bacteremia].Mikrobiyol Bul. 2015 Jul;49(3):446-53. doi: 10.5578/mb.9742. Mikrobiyol Bul. 2015. PMID: 26313286 Turkish.
-
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.Vaccine. 2013 Aug 2;31(35):3577-84. doi: 10.1016/j.vaccine.2013.04.085. Epub 2013 May 18. Vaccine. 2013. PMID: 23688526 Clinical Trial.
Cited by
-
Vaccines and Senior Travellers.Front Aging. 2021 Jul 9;2:677907. doi: 10.3389/fragi.2021.677907. eCollection 2021. Front Aging. 2021. PMID: 35822022 Free PMC article. Review.
References
-
- Hendley JO. Clinical practice. Otitis media. N Engl J Med. 2002;347(15):1169–1174. - PubMed
-
- [Accessed October 16, 2017]. https://www.who.int/immunization/monitoring_surveillance/burden/estimate...
-
- [Accessed October 16, 2017]. https://www.who.int/medicines/areas/priority_medicines/Ch6_22Pneumo.pdf.
-
- Heffron R. Pneumonia, with Special Reference to Pneumococcus Lobar Pneumonia. Cambridge, MA: Harvard University Press; 1939.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources